Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.5390
-0.0322 (-5.64%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Biodesix Stock Forecast
BDSX's stock price has decreased by -57.22% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Biodesix stock have an average target of 2.93, with a low estimate of 2.80 and a high estimate of 3.00. The average target predicts an increase of 443.60% from the current stock price of 0.54.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 16, 2024.
Analyst Ratings
The average analyst rating for Biodesix stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Scotiabank | Scotiabank | Buy Initiates $3 | Buy | Initiates | $3 | +456.59% | Sep 16, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +456.59% | Jul 26, 2024 |
TD Cowen | TD Cowen | Strong Buy Initiates $2.8 | Strong Buy | Initiates | $2.8 | +419.48% | May 13, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +549.35% | Mar 4, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +549.35% | Dec 7, 2023 |
Financial Forecast
Revenue This Year
94.79M
from 71.32M
Increased by 32.90%
Revenue Next Year
118.15M
from 94.79M
Increased by 24.65%
EPS This Year
-0.21
from -0.33
EPS Next Year
-0.14
from -0.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 98.2M | 126.0M | 149.5M |
Avg | 94.8M | 118.2M | 140.4M |
Low | 90.2M | 108.0M | 130.2M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 37.7% | 32.9% | 26.6% |
Avg | 32.9% | 24.6% | 18.8% |
Low | 26.4% | 13.9% | 10.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.20 | -0.09 | -0.04 |
Avg | -0.21 | -0.14 | -0.08 |
Low | -0.22 | -0.20 | -0.11 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.